B6-hCD19
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Model Name
B6-hCD19
Product ID
C001731
Gene Name
Background
C57BL/6NCya
Gene Alias
B4; CVID3
Classification
Tumor Target Humanized Models,Immune Target Humanized Models,Full-Gene Humanized Models,Autoimmune Disease Models
NCBI ID
Phenotype
Chromosome
16
Document
Note: When using this mouse strain in a publication, please cite “B6-hCD19 mice (Catalog C001731) were purchased from Cyagen.”
Strain Description
B6-hCD19 mice are a humanized model generated by replacing the mouse endogenous Cd19 gene sequence from the ATG start codon to part of intron 4 with the corresponding human CD19 gene sequence using gene editing technology. This model is applicable for studying B cell development and function, as well as therapeutic research on autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), and B cell malignancies. It is an ideal research platform for preclinical efficacy evaluation of anti-human CD19 CAR-T cell therapy, and the development of bispecific antibodies and combination therapies.
Application Area
Research on B cell development and function
Mechanism and therapeutic research on autoimmune diseases (e.g., systemic lupus erythematosus, SLE, rheumatoid arthritis, RA) and B cell malignancies, including preclinical efficacy evaluation of anti-human CD19 CAR-T cell therapy, development of bispecific antibodies, and combination therapies
Preclinical research on the development, screening, and pharmacodynamic evaluation of CD19-targeted therapeutic agents
Validation Data